Skip to main content

July 2023

academics

 

Clinical research courses

Applications are invited for Senior Research Fellow at ICT Mumbai

Established on October 1, 1933 as University Department of Chemical Technology (popularly called UDCT) of the University of Bombay (now Mumbai), with the noble intention of advancing India's knowledge reserves in chemical science and technology, the Institute has grown to become a premier (deemed) university devoted to education, training, research and industrial collaboration in chemical engineering, chemical technology, applied chemistry, pharmacy, biotechnology and bio-processing.

Cliantha Research looking for Medical Writer - M.Pharm, B.Pharm, MSc apply

Cliantha Research, a full-service Clinical Research Organization (CRO), is a leading provider of Clinical research services, based in Ahmedabad, India. Cliantha’s motto is Science with Integrity. Cliantha has fifteen years of impeccable regulatory history with USFDA, WHO, MHRA, Health Canada, AGES, AEMPS, MCC, MOH, ANSM, MOPH, ANVISA, CAP, and NABL.

Post : Medical Writer

Walk in for M.Pharm, B.Pharm, MSc in Manufacturing OSD at Amneal Pharma

Amneal Pharmaceuticals, Inc is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry.

Post : Operator / Officer / Sr. Officer / Executive - Manufacturing OSD

Applications invited for Post of Technical Assistant at RMRC - Last Date Extended

The Regional Medical Research Centre (ICMR), Bhubaneswar is a permanent research centre of Indian Council of Medical Research. The foundation stone of the centre was laid by the then prime minister of India Late Mrs. Indira Gandhi on 29th March 1981.Initially the Center started in a small rental accommodation in 1982 and shifted to the Centre’s own building in year 1990 after completion.

Aurobindo Pharma Hiring candidates for API Divisions and Greenfield Projects

AUROBINDO PHARMA LTD is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over USD 2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations.

Hiring candidates for our API Divisions and Greenfield Projects to fill the following Positions in Srikakulam & Visakhapatnam.

Work as Operative Executive Production at Sandoz

Sandoz become a standalone organization! As a global market leader in Generics and Biosimilar medicine, Sandoz is stepping forward from a position of strength! Those joining Sandoz in the coming months will help shape the future of the company, it’s growth, innovation, culture and how Sandoz impacts the lives of millions. These will be careers with genuine impact! This is one such role.

Post : Operative Executive Production ONCO

Walk in for M.Pharm, B.Pharm, MSc in Production, QA, QC at Warren Remedies

Warren Remedies Private Limited is an unlisted private company incorporated on 07 June, 2022. It is classified as a private limited company and is located in Aurangabad, Maharashtra.

Looking for dynamic individuals for our Green Field project at Plot No. 17, Sector-13, AURIC City, Shendra, Dist. Aurangabad.

FDA approves XDEMVY for the treatment of Demodex blepharitis

Tarsus Pharmaceuticals, Inc, whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that the U.S. Food and Drug Administration (FDA) approved XDEMVY (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis. XDEMVY, formerly known as TP-03, is the first and only FDA approved treatment to directly target Demodex mites, the root cause of Demodex blepharitis.

FDA approves Second Over-the-Counter Naloxone Nasal Spray Product

The U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has approved, helping increase consumer access to naloxone without a prescription. The timeline for availability and the price of this nonprescription product will be determined by the manufacturer.

Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies

Alexion, AstraZeneca Rare Disease, announced that it has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy programmes and enabling technologies from Pfizer Inc. (Pfizer). The agreement furthers Alexion and AstraZeneca’s commitment to advancing next-generation genomic medicines with the addition of complementary pipeline assets and innovative technologies.